54 It is apparent from the case-law that the ground of revocation covered by Article 51(1)(c) of Regulation No 207/2009 presupposes the existence of actual deceit or a sufficiently serious risk that the consumer will be deceived (see, to that effect, judgment of 14 May 2009, Fiorucci v OHIM — Edwin (ELIO FIORUCCI), T‐165/06, EU:T:2009:157, paragraph 33; see also, by analogy, judgment of 30 March 2006, Emanuel, C‐259/04, EU:C:2006:215, paragraph 47).
Interazione con indinavir/ritonavir non studiata I livelli di R-warfarin possono essere diminuiti con conseguente ridotta attività anticoagulante a causa dell' induzione di CYP#A# e CYP#C# da parte di ritonavireurlex-diff-2018-06-20 eurlex-diff-2018-06-20